Buserelin

Records for this ingredient, by country (identity only).

ATC L02AE01 · 5 markets · 19 records

Buserelin 5 markets · 19 records Forms
Filters

GB 6 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19 · some records have no stated strength

  • 5.5 mg/5.5 mLinjectionSuprecur 5.5mg/5.5ml solution for injection vialsSuprefact 5.5mg/5.5ml solution for injection vials、Manufacturer: Alliance Healthcare (Distri…、Manufacturer: Neon Healthcare Ltd
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Suprecur 150micrograms/dose nasal spray ×1Suprefact 100micrograms/dose nasal spray ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 1 mg per mL / per unit basis not statedliquidSUPREFACT

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 15.75 mg/10 mLnasalブセレリン酢酸塩15.75mg10mL点鼻液

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.